FOR IMMEDIATE RELEASE

L.A. City Films Announces Hollywood Screening & Medical Lecture on Individually Dosed Hyperbaric Oxygen Therapy by Paul G. Harch, M.D.

HOLLYWOOD, CA (Feb. 28, 2026) — L.A. City Films announces a special Hollywood screening of Undeniable Evidence: Clean Medicine. Dirty Politics., followed by a 20-minute medical lecture by Paul G. Harch, M.D., Medical Director of Harch Hyperbarics. The event will take place on Saturday, February 28, 2026 at 10:00 a.m. at the TCL Chinese Theatre, steps from the Hollywood Walk of Fame.

Dr. Harch’s lecture will focus on a central issue in modern hyperbaric oxygen therapy: dose. Hyperbaric oxygen is regulated as a drug, and—like any drug—its outcomes depend on dose, patient response, and appropriate clinical oversight.

During the lecture, Dr. Harch will present his Patent Pending approach to qEEG-based hyperbaric oxygen therapy dosing, using quantitative electroencephalogram (qEEG) technology to help identify how an individual brain responds to different pressure and oxygen levels.

“Hyperbaric oxygen is not a guessing game,” said Dr. Harch. “The same protocol given to everyone can produce uneven results. Individualized dosing is the missing step.”

A growing problem in the public perception of hyperbaric oxygen therapy is that it is increasingly offered in non-medical and minimally supervised settings, often marketed as simple and universally effective. The reality is far more complex.

The rapid expansion of hyperbaric oxygen into non-medical environments has contributed to uneven outcomes and, in rare but documented cases, serious safety incidents. These events have damaged public trust in a therapy that—when properly prescribed and medically supervised—functions like any other drug, with outcomes dependent on dose, patient response, and clinical oversight.

When hyperbaric oxygen is delivered without individualized dosing or physician supervision, outcomes become unpredictable—reinforcing the misconception that the therapy itself is unreliable.

Dr. Harch has spent decades in hyperbaric medicine and has refined a brain-focused, individualized dosing workflow over the last ten years. This process integrates qEEG response testing to better match hyperbaric treatment parameters to patient physiology.

EVENT DETAILS

• Screening: Undeniable Evidence: Clean Medicine. Dirty Politics.
• Medical Lecture: “Individually Dosed HBOT Using qEEG (Quantitative EEG)” (Patent Pending)
• Date & Time: Saturday, February 28, 2026 — 10:00 a.m.
• Location: TCL Chinese Theatre, Hollywood, California

FOR PATIENTS & MEDIA INQUIRIES

Harch Hyperbarics
Phone: (504) 309-4948
More information: HBOT.com